Rodgers Silicon Valley Acquisition Corp. (NASDAQ:RSVA) announced in a press release today that its shareholders approved its combination with next-generation 3D Silicon™ Lithium-ion battery manufacturer Enovix at a special meeting held on July 12.
The release did not include redemption numbers, but Rodgers Silicon Valley traded above $20 throughout July 8, the day of its redemption deadline, and opened today at $22.04.
The combined entity’s shares and warrants will start trading on the Nasdaq under the new symbols “ENVX” and “ENVXW”, respectively, on Thursday, July 15.
The transaction resulted in approximately $405 million of gross cash proceeds, before expenses, which will allow Enovix to build out its first two production facilities to support demand from blue chip customers in the global mobile computing market while continuing to develop cells for Electric Vehicles (EVs).
Rodgers Silicon Valley and Enovix initially announced the $1.128 billion deal on February 22. Enovix’s initial goal is to provide designers of category-leading mobile devices with a high-energy battery so they can create more innovative and effective portable products. The company is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable widespread utilization of renewable energy.
Battery technology companies have been hot. Quantumscape (NYSE:QS), also a battery cell technology company, announced its $3.3 billion deal with Kensington (NYSE:KCAC) a few months prior to Evonix back in September where the markets soared in response to the news. RSVA struck while the iron was still hot as it was able to negotiate PIPE investors up to $14 per share in hopes that it would be next Quantumscape deal. QS’s deal successfully closed with low redemptions in late November and opened today at $24.28.
Enovix ramped up hiring last week with five new additions to its leadership team to accelerate expansion ahead of the closing of its deal.
ADVISORS
- Oppenheimer & Co. Inc. is serving as financial advisor to Rodgers Silicon Valley Acquisition Corp.
- Loeb & Loeb LLP is serving as legal advisor to Rodgers Silicon Valley Acquisition Corp.
- Oppenheimer & Co. Inc. and Williams Trading, LLC are serving as placement agents on the PIPE offering.
- Cooley LLP is serving as legal advisor to Enovix
- Winston & Strawn LLP is serving as legal advisor to the placement agents.
At the SPAC of Dawn The SPAC world is set to get its newest member later today when Launch Two (NASDAQ:LPBBU) begins trading having priced its $200 million IPO overnight. The technology SPAC is the first to IPO this quarter and comes after the newfound SPAC issuance momentum appeared to throttle down slightly in September,...
Launch Two Acquisition Corp. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LPBBU”, Tuesday, October 8, 2024. The new SPAC’s primary search focus will be on technology and software infrastructure companies whose products and services target financial services, real estate and...
Oaktree III Life Sciences (NASDAQ:OACCU) has filed for a $175 million SPAC with some of the most aggressively team-friendly terms seen so far in the second half of 2024. The new SPAC’s units contain 1/5 warrants and the trust is not set to be overfunded. Only the warrantless Cantor Equity Partners (NASDAQ:CEP) has IPO’d so...
At the SPAC of Dawn SPACs are set to have a sleepy start to their post-Rosh Hashanah week with no votes on the docket until Wednesday. Three SPACs are to hold extension votes that day and Clover Leaf (OTC:CLOE) will try again to close its combination with Kustom Entertainment after several adjournments on Friday. In...
Terms Tracker for the Week Ending October 4, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This week was much, much heavier on the S-1 filings. There were five new SPACs filed along with six amended S-1 registration statements making good...